Life Tech Alliance is Latest FDA Move to Incorporate Sequencing Data into Food Pathogen Detection | GenomeWeb

A five-year deal between the US Food and Drug Administration and Life Technologies marks the latest sequencing-related move in the federal agency's ongoing efforts to characterize, detect, and track foodborne pathogens.

The agreement focuses on using genome sequence data as a source of information for finding markers that can be incorporated into rapid molecular tests to detect and distinguish between various strains and serotypes of Escherichia coli and Salmonella.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.